SK
ZBH icon

Sarah Ketterer’s Zimmer Biomet ZBH Stock Holding History

Sarah Ketterer’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.9M Sell
788,810
-19,300
-2% -$1.69M 0.74% 26
2026
Q1 		$73.1M Buy
808,110
+79,612
+11% +$7.31M 0.9% 23
2025
Q4 		$65.5M Buy
728,498
+146,719
+25% +$13.9M 0.9% 25
2025
Q3 		$57.3M Buy
581,779
+3,541
+0.6% +$351K 0.76% 28
2025
Q2 		$52.7M Sell
578,238
-227,271
-28% -$22M 0.83% 24
2025
Q1 		$91.2M Buy
805,509
+35,577
+5% +$3.81M 1.91% 9
2024
Q4 		$81.3M Sell
769,932
-24,356
-3% -$2.61M 1.85% 9
2024
Q3 		$85.7M Buy
794,288
+133,482
+20% +$14.6M 2.11% 11
2024
Q2 		$71.7M Buy
660,806
+154,551
+31% +$18.2M 1.96% 12
2024
Q1 		$66.8M Sell
506,255
-58,414
-10% -$7.3M 1.75% 14
2023
Q4 		$68.7M Buy
564,669
+158,806
+39% +$17.7M 1.75% 16
2023
Q3 		$45.5M Buy
405,863
+179,845
+80% +$22.8M 1.2% 24
2023
Q2 		$32.9M Sell
226,018
-197,872
-47% -$26.9M 0.87% 33
2023
Q1 		$54.8M Sell
423,890
-8,072
-2% -$1.01M 1.31% 19
2022
Q4 		$55.1M Sell
431,962
-27,247
-6% -$3.16M 1.6% 16
2022
Q3 		$48M Sell
459,209
-62,564
-12% -$6.87M 1.35% 21
2022
Q2 		$54.8M Sell
521,773
-34,425
-6% -$4.08M 1.37% 21
2022
Q1 		$71.1M Buy
556,198
+307,079
+123% +$37M 1.7% 23
2021
Q4 		$30.7M Buy
+249,119
New +$32.6M 0.68% 41
2019
Q4 		– Sell
-1,039,700
Closed -$139M – 95
2019
Q3 		$139M Sell
1,039,700
-99,135
-9% -$12.8M 1.66% 21
2019
Q2 		$130M Buy
1,138,835
+58,702
+5% +$6.88M 1.42% 24
2019
Q1 		$134M Sell
1,080,133
-274,794
-20% -$31.2M 1.35% 22
2018
Q4 		$136M Buy
1,354,927
+106,091
+8% +$11.9M 1.63% 22
2018
Q3 		$159M Buy
1,248,836
+25,337
+2% +$3.01M 1.6% 22
2018
Q2 		$132M Buy
+1,223,499
New +$133M 1.34% 24

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sarah Ketterer's ZBH Position: Q2 2026 in Review

Sarah Ketterer reduced its Zimmer Biomet (ZBH) stake by 2.4% in Q2 2026, selling an estimated $1.69M and leaving 788,810 shares worth $67.9M. The position accounts for 0.74% of the portfolio, ranked #26.

Sarah Ketterer first reported a position in ZBH in Q2 2018 and has held it in 25 quarters since. The position peaked at $159M in Q3 2018. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Sarah Ketterer held 788,810 shares of Zimmer Biomet worth $67.9M as of Q2 2026.
  • Sarah Ketterer sold 19,300 Zimmer Biomet shares in Q2 2026, an estimated $1.69M.
  • Zimmer Biomet made up 0.74% of Sarah Ketterer's portfolio in Q2 2026, its #26 holding.
  • Sarah Ketterer first reported a position in Zimmer Biomet in Q2 2018 and has held it in 25 quarters since.
  • Sarah Ketterer's Zimmer Biomet position peaked at $159M in Q3 2018.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.